Consortium of Melanoma Centers of Pennsylvania advances prevention, treatment

April 17, 2013

Penn State Hershey Melanoma Center is leading a statewide collaboration designed to advance melanoma prevention and treatment. The Consortium of Melanoma Centers of Pennsylvania was established in February and includes melanoma centers and programs from Penn State, University of Pennsylvania, Thomas Jefferson, The Wistar Institute, St Luke’s Hospital, Temple University/Fox Chase and the University of Pittsburgh. The consortium is the first of its kind in the melanoma arena and will significantly advance efforts to prevent and treat melanoma.

The consortium serves as a resource for researchers, clinicians and melanoma patients. It provides its members with opportunities to collaborate, calling upon complementary expertise and resources to address many of the obstacles associated with this disease.

Clinicians from the consortium have access to melanoma patients from all sites for accrual to personalized therapeutic trials. Patients can also easily access up-to-date information regarding the latest clinical trials at each institution. The consortium also addresses legislative issues related to the disease and interacts with grassroots organizations and foundations.

For more information about the consortium, visit

(Media Contacts)

Last Updated April 17, 2013